Search results for "Venous thromboembolism"
Extended anticoagulant treatment prevents recurrent VTE after first unprovoked PE
An additional 18 months of warfarin treatment in patients with first unprovoked PE improves outcomes versus placebo, although the improvement was not sustained after anticoagulant treatment was discontinued.
https://immattersacp.org/weekly/archives/2015/07/14/2.htm
14 Jul 2015
Genotype testing for warfarin dosing may offer limited or no benefit
Genotyping for warfarin therapy has limited, if any, benefit, according to 3 recent studies and an editorial.
https://immattersacp.org/weekly/archives/2013/11/26/1.htm
26 Nov 2013
MKSAP Quiz: Painful rash occurring bilaterally
A 32-year-old woman is evaluated for a painful rash occurring bilaterally on her lower extremities, which began 2 days ago. She was admitted to the hospital 5 days ago for diagnosis and treatment of pulmonary embolism with heparin and warfarin. Her father had a pulmonary embolism after a long airplane ride. Following a physical exam and lab studies, what is the most likely diagnosis?
https://immattersacp.org/archives/2019/02/mksap-quiz-painful-rash-occurring-bilaterally.htm
1 Feb 2019
Outcomes of limited cancer screening after unprovoked VTE similar to extensive screening
The overall prevalence of cancer in the 12 months after a diagnosis of venous thromboembolism was 5.2%. While the point prevalence was higher in patients receiving extensive screening than in those receiving limited screening, there was no significant difference at one year.
https://immattersacp.org/weekly/archives/2017/08/22/4.htm
22 Aug 2017
To test or not to test for inherited thrombophilias
First consider whether a deep venous thrombosis was provoked or unprovoked, as well as at the type of provoking factors.
https://immattersacp.org/archives/2019/06/to-test-or-not-to-test-for-inherited-thrombophilias.htm
1 Jun 2019
Thoracic society releases guidelines on pulmonary hypertension in sickle cell patients
The American Thoracic Society recently released clinical practice guidelines to help clinicians identify and manage patients with sickle cell disease who are at increased risk for death from pulmonary hypertension.
https://immattersacp.org/weekly/archives/2014/03/18/4.htm
18 Mar 2014
Approvals for an oral anticoagulant, generic esomeprazole
This update covers the approval of an oral medication to reduce the risk of stroke and embolism in atrial fibrillation and the first generic version of esomeprazole.
https://immattersacp.org/archives/2015/04/fda.htm
1 Apr 2015
Special Focus: Diagnosing Pulmonary Embolism
Evidence-based recommendations about care.
https://immattersacp.org/archives/2008/01/special.htm
1 Jan 2008
ACP workgroup compiles list of low-value tests
A workgroup of internists convened by ACP has developed a list of 37 clinical situations in which medical tests are commonly used but do not provide high value.
https://immattersacp.org/weekly/archives/2012/01/24/2.htm
24 Jan 2012
AHA issues statement on cerebral venous thrombosis diagnosis, management
MKSAP Quiz: drug-resistant hypertension
https://immattersacp.org/weekly/archives/2011/02/15/2.htm
15 Feb 2011